Glucose tolerance status in patients with newly diagnosed papillary thyroid carcinoma
Glucose tolerance status in patients with newly diagnosed papillary thyroid carcinoma
نویسندگان: ناصر آقا محمد زاده , تقی فدائی حقی , جلیل هوشیار قراملکی , فرزاد نجفی پور
کلمات کلیدی: Papillary thyroid cancer, Insulin resistance, Oral glucose tolerance test
نشریه: 0 , 2 , 7 , 2020
| نویسنده ثبت کننده مقاله |
فرزاد نجفی پور |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات غدد درون ریز |
| کد مقاله |
74935 |
| عنوان فارسی مقاله |
Glucose tolerance status in patients with newly diagnosed papillary thyroid carcinoma |
| عنوان لاتین مقاله |
Glucose tolerance status in patients with newly diagnosed papillary thyroid carcinoma |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
Immunopathol Persa |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Introduction: Thyroid cancer is one of the most common endocrine system malignancies with 9 out of 100,000
estimated annual incidence and papillary carcinoma is the most common type of thyroid cancer. Papillary thyroid
cancer (PTC) increases blood insulin levels by creating insulin resistance. Many studies have suggested the role of
insulin resistance in the prognosis of PTC.
Objectives: The aim of the present study was to determine the prevalence of impaired glucose tolerance in
patients with PTC and to compare the relationship between insulin resistance and disease severity, lymph node
involvement and distant metastasis.
Patients and Methods: In this cross-sectional study, 68 patients with PTC diagnosis examined for metastasis by
whole body scan and cervical lymph nodes by ultrasound were included in this study. A 75 g oral glucose
tolerance test was also performed on subjects.
Results: In this study 68 patients (76.5% female and 23.5% male) were enrolled. The mean age of the patients
was 44.2 ± 13.8 years. The mean serum level of fasting blood glucose (FBG in patients was 103.14 ± 21.8 mg/dL
and the mean 2 hours past-prandial was 145.12 ± 22.37 mg/dL. Statistically significant lymphatic involvement was
observed in 25% of patients between insulin resistance and nodal involvement (P = 0.03). A significantly higher
metastasis was also observed in 16.2% of patients with glucose intolerance (P < 0.05).
Conclusion: The results indicated that the rate of insulin resistance in PTC patients is significantly higher and
glucose intolerance in these patients is associated with increased lymphatic involvement and increased risk of
metastasis and poor prognosis. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| ipp-18218.pdf | 1399/11/05 | 257044 | دانلود |